FDA Inspection
Mary Bird Perkins Cancer CenterMary Bird Perkins Cancer Center – FDA Inspection, Apr 30, 2015
Record Details
This FDA Inspection record concerns Mary Bird Perkins Cancer Center, with an inspection on April 30, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 30, 2015
- Product Type
- Biologics
View Company Profile
ID · c7b09992-0a44-40d5-91e9-6f58e32b3ebf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 926021
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mary Bird Perkins Cancer Center
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 13, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 27, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 9, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 5, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Mary Bird Perkins Cancer Center
- FDA Inspection 1279775 - 2025-08-18
- FDA Inspection 1203081 - 2023-04-13
- FDA Inspection 1102024 - 2019-08-27
- FDA Inspection 999716 - 2017-02-09
- FDA Inspection 817164 - 2013-02-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.